PharmDr. Martin Čulen, Ph.D.

Assistant professor, Department of Internal Medicine, Hematology and Oncology

correspondence Address:
Jihlavská 340/20, 625 00 Brno

office: bldg. F01B2/156
Kamenice 126/3
625 00 Brno

phone:	+420 532 23 4641
e‑mail:

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 62

2022

Prediction of novel treatment options for CLL and AML cells based on drug repurposing.

LADUNGOVÁ Adriana BUŠA Daniel PESCHELOVÁ Helena LODHI Yusuf ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract
Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing.

LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract
Selected Analytical Techniques of Solid State, Structure Identification, and Dissolution Testing in Drug Life Cycle. Analytical Techniques in Drug Life Cycle

ČULEN Martin DOHNAL Jiří JAMPÍLEK

Editorship of scientific publication

Year: 2022, type: Editorship of scientific publication

2021

Acute myeloid leukemia regression induced by palbociclib and ponatinib in patient –derived xenograft model.

BUŠA Daniel LOJA Tomáš JEŽÍŠKOVÁ Ivana FOLTA A. MAYER Jiří ČULEN Martin

Conference abstract

Year: 2021, type: Conference abstract
Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up

ROMŽOVÁ Marianna SMITALOVÁ Dagmar HYNŠT Jakub TOM Nikola LOJA Tomáš HERUDKOVÁ Zdeňka JURČEK Tomáš STEJSKAL Lukas ŽÁČKOVÁ Daniela MAYER Jiří RÁČIL Zdeněk ČULEN Martin

Article in Periodical

British journal of haematology, year: 2021, volume: 194, edition: 3, DOI
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro

LEDEREROVÁ Aneta DOSTÁLOVÁ Lenka KOZLOVÁ Veronika PESCHELOVÁ Helena LADUNGOVÁ Adriana ČULEN Martin LOJA Tomáš VERNER Jan POSPÍŠILOVÁ Šárka ŠMÍDA Michal MANČÍKOVÁ Veronika

Article in Periodical

Journal for ImmunoTherapy of Cancer, year: 2021, volume: 9, edition: 8, DOI
Palbociclib and ponatinib induce regression of acute myeloid leukemia in patient-derived xenograft model.

BUŠA Daniel LOJA Tomáš JEŽÍŠKOVÁ Ivana FOLTA Adam MAYER Jiří ČULEN Martin

Conference abstract

Year: 2021, type: Conference abstract
Prehľad biorelevantných dynamických disolučných prístrojov

BÍLIK Tomáš STUPÁK Ivan VYSLOUŽIL Jakub ČULEN Martin DOHNAL Jiří

Article in Periodical

CHEMICKÉ LISTY, year: 2021, volume: 115, edition: 11

2020

Clonal hierarchy of main molecular lesions in acute myeloid leukaemia

HERUDKOVÁ Zdeňka ČULEN Martin FOLTA Adam JEŽÍŠKOVÁ Ivana CERNA Jana LOJA Tomáš TOM Nikola SMEJKAL Jiri SEMERÁD Lukáš DVOŘÁKOVÁ Dana MAYER Jiří RÁČIL Zdeněk

Article in Periodical

British journal of haematology, year: 2020, volume: 190, edition: 4, DOI
Generation of humanized bone marrow-like niche for leukemic xenotransplantation in mice: comparison of biomaterials

HERUDKOVÁ Zdeňka SOKOL Filip VLAŽNÝ Jakub LIŠKOVÁ Květoslava KŘEN Leoš REPKO Martin VOJTOVÁ Lucy ŠUSTKOVÁ Zuzana RÁČIL Zdeněk MAYER Jiří ČULEN Martin

Conference abstract

Year: 2020, type: Conference abstract

Projects

Teaching

10 reasons why you will fall in love with MU

Ask our ambassador

Read about research at MU

PharmDr. Martin Čulen, Ph.D.

2022

Prediction of novel treatment options for CLL and AML cells based on drug repurposing.

Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing.

Selected Analytical Techniques of Solid State, Structure Identification, and Dissolution Testing in Drug Life Cycle. Analytical Techniques in Drug Life Cycle

2021

Acute myeloid leukemia regression induced by palbociclib and ponatinib in patient –derived xenograft model.

Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up

Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro

Palbociclib and ponatinib induce regression of acute myeloid leukemia in patient-derived xenograft model.

Prehľad biorelevantných dynamických disolučných prístrojov

2020

Clonal hierarchy of main molecular lesions in acute myeloid leukaemia

Generation of humanized bone marrow-like niche for leukemic xenotransplantation in mice: comparison of biomaterials